APOA2 Antikörper (C-Term)
Kurzübersicht für APOA2 Antikörper (C-Term) (ABIN4888992)
Target
Alle APOA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with human and primate Apo-AII
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide derived from C terminal part of human APOA2 protein.
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1:200 - 1:5000 IHC1:100 - 1:2000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- APOA2 (Apolipoprotein A-II (APOA2))
-
Andere Bezeichnung
- Apolipoprotein A-II (Apo-AII)
-
Hintergrund
- Belongs to the apolipoprotein A2 family. Involved in host-virus interaction.
-
Gen-ID
- 336
-
UniProt
- P02652
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Target
-